A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Hormone Receptor Positive
Interventions: DRUG: Palbociclib|DRUG: Tamoxifen|DRUG: Fulvestrant
Sponsor: University of California, San Francisco
Collaborators: Translational Breast Cancer Research Consortium|Dana-Farber Cancer Institute